Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Open Access
- 16 January 2024
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (2)
Abstract
Immunometabolism is a burgeoning field of research that investigates how immune cells harness nutrients to drive their growth and functions. Myeloid cells play a pivotal role in tumor biology, yet their metabolic influence on tumor growth and antitumor immune responses remains inadequately understood. This Review explores the metabolic landscape of tumor-associated macrophages, including the immunoregulatory roles of glucose, fatty acids, glutamine, and arginine, alongside the tools used to perturb their metabolism to promote antitumor immunity. The confounding role of metabolic inhibitors on our interpretation of myeloid metabolic phenotypes will also be discussed. A binary metabolic schema is currently used to describe macrophage immunological phenotypes, characterizing inflammatory M1 phenotypes, as supported by glycolysis, and immunosuppressive M2 phenotypes, as supported by oxidative phosphorylation. However, this classification likely underestimates the variety of states in vivo. Understanding these nuances will be critical when developing interventional metabolic strategies. Future research should focus on refining drug specificity and targeted delivery methods to maximize therapeutic efficacy.Keywords
This publication has 165 references indexed in Scilit:
- The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose MetabolismCell Metabolism, 2012
- Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2Cell, 2011
- Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1aCell Metabolism, 2011
- IL4I1: an inhibitor of the CD8+ antitumor T‐cell response in vivoEuropean Journal of Immunology, 2011
- A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidationJournal of Inherited Metabolic Disease, 2010
- The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesLeukemia, 2009
- A catabolic block does not sufficiently explain how 2-deoxy-d-glucose inhibits cell growthProceedings of the National Academy of Sciences, 2008
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerBritish Journal of Cancer, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005